Memphis-based SurgiVision Inc., which provides technology that makes possible a better MRI look-see into the brain or heart, is awaiting an FDA authorization for advancing its product, and, beyond that, hopes to launch an IPO to raise about $30MM. The CA reports. The company, led by former Morgan Keegan PE director Kimble Jenkins, has 20 employees and is allied with Siemens and Boston Scientific. SEC filing.
Wednesday, December 30, 2009
SurgiVision's IPO dream
Memphis-based SurgiVision Inc., which provides technology that makes possible a better MRI look-see into the brain or heart, is awaiting an FDA authorization for advancing its product, and, beyond that, hopes to launch an IPO to raise about $30MM. The CA reports. The company, led by former Morgan Keegan PE director Kimble Jenkins, has 20 employees and is allied with Siemens and Boston Scientific. SEC filing.
Labels:
IPO,
life sciences,
medical technology,
SurgiVision
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment